# OnCo record nct05945901 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05945901/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05945901", "NCT05945901" ;
  schema:name "A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer"@en ;
  schema:description "A phase 2/3 trial testing HR070803 in colorectal cancer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05945901/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05945901> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2023-08-14" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/hr070803/> ;
  onco:companies <https://onco.cc/companies/hengrui/> .